• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存在人乳头瘤病毒阴性的宫颈癌吗?

Do HPV-negative cervical carcinomas exist?

作者信息

Walboomers J M, Meijer C J

出版信息

J Pathol. 1997 Mar;181(3):253-4. doi: 10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0.

DOI:10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0
PMID:9155707
Abstract

Based on improvements in HPV detection technology, it appears that an almost 100% HPV association is reached for cervical cancer, as demonstrated in an accompanying paper in this issue of the Journal. Factors which may explain the rare cases in which no HPV DNA is detectable include: improper sampling; disruption of HPV by integration events; the existence of still unidentified HPVs; sensitivity of the method; and the mechanism of transformation. Finally, epidemiological studies identifying HPV independent risk factors are necessary to answer the question of whether HPV independent pathways exist for cervical carcinogenesis.

摘要

基于人乳头瘤病毒(HPV)检测技术的改进,本期《杂志》的一篇相关论文表明,宫颈癌与人乳头瘤病毒的关联度几乎达到了100%。对于罕见的无法检测到HPV DNA的病例,可能的解释因素包括:采样不当;整合事件导致HPV被破坏;仍未识别的HPV的存在;检测方法的灵敏度;以及转化机制。最后,需要开展确定HPV独立风险因素的流行病学研究,以解答宫颈癌发生过程中是否存在HPV独立途径这一问题。

相似文献

1
Do HPV-negative cervical carcinomas exist?存在人乳头瘤病毒阴性的宫颈癌吗?
J Pathol. 1997 Mar;181(3):253-4. doi: 10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0.
2
Do HPV-negative cervical carcinomas exist?--revisited.
J Pathol. 1999 Sep;189(1):1-3. doi: 10.1002/(SICI)1096-9896(199909)189:1<1::AID-PATH432>3.0.CO;2-P.
3
[Integrating HPV testing for primary screening?].[将人乳头瘤病毒检测纳入初筛?]
J Gynecol Obstet Biol Reprod (Paris). 2008 Feb;37 Suppl 1:S139-51. doi: 10.1016/j.jgyn.2007.11.020. Epub 2008 Jan 8.
4
"Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.人宫颈癌中“低风险”和“高风险”人乳头瘤病毒感染及K-ras基因点突变:31例研究
Pathol Res Pract. 2001;197(9):597-603.
5
HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.在罹患宫颈癌的女性中,人乳头瘤病毒(HPV)的存在先于细胞学异常,并提示涂片检查假阴性。
Br J Cancer. 2001 Aug 3;85(3):398-404. doi: 10.1054/bjoc.2001.1926.
6
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.在全球范围内,人乳头瘤病毒是浸润性宫颈癌的必要病因。
J Pathol. 1999 Sep;189(1):12-9. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
7
Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.用于聚合酶链反应检测人乳头瘤病毒的人乳头瘤病毒通用引物的评估
Mol Cell Probes. 1999 Feb;13(1):9-21. doi: 10.1006/mcpr.1998.0203.
8
Detection of HPV DNA in cervical carcinomas by PCR and hybrid capture assay.
Indian J Pathol Microbiol. 2003 Oct;46(4):596-9.
9
Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.宫颈癌患者血浆中人乳头瘤病毒DNA的检测与定量分析
Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):3-6.
10
Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.使用原位聚合酶链反应检测人乳头瘤病毒在宫颈腺癌和腺鳞癌中的定位:这些癌症中人乳头瘤病毒检测的文献综述
Pathol Int. 2006 Jun;56(6):301-8. doi: 10.1111/j.1440-1827.2006.01964.x.

引用本文的文献

1
The Potential Impact of a Single-Dose HPV Vaccination Schedule on Cervical Cancer Outcomes in Kenya: A Mathematical Modelling and Health Economic Analysis.单剂量人乳头瘤病毒疫苗接种方案对肯尼亚宫颈癌结局的潜在影响:一项数学建模与卫生经济分析
Vaccines (Basel). 2024 Nov 1;12(11):1248. doi: 10.3390/vaccines12111248.
2
Incidence and Clinicopathologic Characteristics of Human Papillomavirus-independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases.人乳头瘤病毒非依赖性宫颈浸润性鳞状细胞癌的发生率和临床病理特征:670 例形态学、免疫组织化学和人乳头瘤病毒病毒学研究。
Am J Surg Pathol. 2023 Dec 1;47(12):1376-1389. doi: 10.1097/PAS.0000000000002122. Epub 2023 Sep 13.
3
The Clinical Efficacy of Chemotherapy Combined with Traditional Chinese Medicine in the Treatment of Cervical Cancer and Its Influence on Cellular Immunity, Serum CEA, and TNF-.化疗联合中药治疗宫颈癌的临床疗效及其对细胞免疫、血清癌胚抗原和肿瘤坏死因子-α的影响
Evid Based Complement Alternat Med. 2022 Jan 7;2022:7728739. doi: 10.1155/2022/7728739. eCollection 2022.
4
Potential anticancer activity of Acetone extracts of , and on HeLa cervical cancer cells.、 和 的丙酮提取物对 HeLa 宫颈癌癌细胞的潜在抗癌活性。
Afr Health Sci. 2021 Jun;21(2):663-672. doi: 10.4314/ahs.v21i2.23.
5
Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer.混合和非疫苗高危型 HPV 与宫颈癌黑人女性的死亡率升高相关。
Sci Rep. 2021 Jul 7;11(1):14064. doi: 10.1038/s41598-021-93485-1.
6
Validation of the cobas 6800 human papillomavirus test in primary cervical screening.cobas 6800人乳头瘤病毒检测在子宫颈癌初筛中的验证
PLoS One. 2021 Feb 19;16(2):e0247291. doi: 10.1371/journal.pone.0247291. eCollection 2021.
7
Long noncoding RNA MACC1-AS1 is a potential sponge of microRNA-34a in cervical squamous cell carcinoma and upregulates cyclin-dependent kinase 6.长链非编码RNA MACC1-AS1是宫颈鳞状细胞癌中微小RNA-34a的潜在海绵分子,并上调细胞周期蛋白依赖性激酶6。
Oncol Lett. 2020 Mar;19(3):2339-2345. doi: 10.3892/ol.2020.11346. Epub 2020 Jan 24.
8
Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.评估一种新的低成本、基于 PCR 的策略,用于检测高危型人乳头瘤病毒 DNA 以预防宫颈癌。
BMC Infect Dis. 2019 Oct 15;19(1):842. doi: 10.1186/s12879-019-4527-9.
9
Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer.HPV70 引起的插入性致癌作用在临床 HPV 阴性宫颈癌的多重基因组分析中得到揭示。
Genes Chromosomes Cancer. 2020 Feb;59(2):84-95. doi: 10.1002/gcc.22799. Epub 2019 Sep 4.
10
HPV-negative Tumors in a Swedish Cohort of Cervical Cancer.瑞典宫颈癌队列中的人乳头瘤病毒阴性肿瘤
Int J Gynecol Pathol. 2020 May;39(3):279-288. doi: 10.1097/PGP.0000000000000612.